HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Correlation between EGF receptor expression and peplomycin cytotoxicity in squamous cell carcinoma cell lines.

Abstract
The relationship between sensitivity to anti-cancer agents and EGF receptor expression on squamous cell carcinoma (SCC) cells was investigated. The cytotoxicity of peplomycin (PEP) was correlated with the number of the EGF receptors expressed on the cancer cells, but no correlations were found between the cytotoxicity of adriamycin and cisplatin and EGF receptors. Addition of TNFalpha increased the number of EGF receptors in the SCC cell lines 1.5- to 2-fold. The cytotoxic effect of combined administration of PEP and TNFalpha was correlated with the number of EGF receptors, and produced a 2- to 5-fold increase in IC50 compared with administration of PEP alone. These observations suggest that EGF receptor expression is closely associated with the cytotoxic effect of PEP on SCC cells.
AuthorsM Osaku, M Ueda, T Miyakawa, H Toyoda, K Uesato, Y Yamada, F Asanuma, N Ando, S Ozawa, Y Kitagawa, M Kitajima
JournalOncology reports (Oncol Rep) 2001 Jul-Aug Vol. 8 Issue 4 Pg. 855-60 ISSN: 1021-335X [Print] Greece
PMID11410798 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibiotics, Antineoplastic
  • Antibodies, Monoclonal
  • Tumor Necrosis Factor-alpha
  • Peplomycin
  • Doxorubicin
  • ErbB Receptors
  • Cisplatin
Topics
  • Antibiotics, Antineoplastic (toxicity)
  • Antibodies, Monoclonal (therapeutic use)
  • Carcinoma, Squamous Cell (drug therapy, metabolism)
  • Cell Survival
  • Cisplatin (toxicity)
  • Doxorubicin (toxicity)
  • Drug Screening Assays, Antitumor
  • ErbB Receptors (metabolism)
  • Esophageal Neoplasms (drug therapy, metabolism)
  • Female
  • Gingival Neoplasms (drug therapy, metabolism)
  • Humans
  • Peplomycin (toxicity)
  • Regression Analysis
  • Tumor Cells, Cultured (drug effects, metabolism)
  • Tumor Necrosis Factor-alpha (pharmacology)
  • Vulvar Neoplasms (drug therapy, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: